{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:28:08Z","timestamp":1786112888647,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1097\/01.pas.0000213273.22844.1a","type":"journal-article","created":{"date-parts":[[2006,10,20]],"date-time":"2006-10-20T04:38:38Z","timestamp":1161319118000},"page":"1357-1366","source":"Crossref","is-referenced-by-count":36,"title":["Morphology of Breast Cancer as a Means of Triage of Patients for BRCA1 Genetic Testing"],"prefix":"10.1097","volume":"30","author":[{"given":"Gelareh","family":"Farshid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary L.","family":"Balleine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Waring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210130","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N","article-title":"The histologic phenotype of breast carcinomas occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population based study","volume":"83","author":"Armes","year":"1998","journal-title":"Cancer"},{"key":"R2-2-20210130","first-page":"2011","article-title":"Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study","volume":"59","author":"Armes","year":"1999","journal-title":"Cancer Res"},{"key":"R3-2-20210130","first-page":"1730","article-title":"Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility","volume":"14","year":"1996","journal-title":"J Clin Oncol"},{"key":"R4-2-20210130","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","article-title":"BRACPRO validation, sensitivity of genetic testing pf BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes","volume":"20","author":"Berry","year":"2002","journal-title":"J Clin Oncol"},{"key":"R5-2-20210130","first-page":"1739","article-title":"Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients","volume":"7","author":"Chang","year":"2001","journal-title":"Clin Cancer Res"},{"key":"R7-2-20210130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/(SICI)1098-2264(200002)27:2<130::AID-GCC3>3.0.CO;2-U","article-title":"Comparison between genotype and phenotype identifies a high risk population carrying BRCA1 mutation","volume":"27","author":"Cortesi","year":"2000","journal-title":"Genes Chromosomes Cancer"},{"key":"R8-2-20210130","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","article-title":"BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer","volume":"336","author":"Couch","year":"1997","journal-title":"N Engl J Med"},{"key":"R9-2-20210130","first-page":"805","article-title":"Why are the majority of hereditary cases of early-onset breast cancer sporadic? A simulation study [In Process Citation]","volume":"9","author":"Cui","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R10-2-20210130","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/jama.280.14.1227","article-title":"BRCA1 and medullary breast cancer","volume":"280","author":"Eisinger","year":"1998","journal-title":"J Am Med Assoc"},{"key":"R11-2-20210130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1097-0215(19990621)84:3<263::AID-IJC11>3.0.CO;2-G","article-title":"Novel indications for BRCA1 screening using individual clinical and morphological features","volume":"84","author":"Eisinger","year":"1999","journal-title":"Int J Cancer"},{"key":"R13-2-20210130","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/jnci\/94.11.844","article-title":"Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO","volume":"94","author":"Euhus","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R14-2-20210130","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1126\/science.278.5340.1043","article-title":"Human cancer syndromes: clues to the origin and nature of cancer","volume":"278","author":"Fearon","year":"1997","journal-title":"Science"},{"key":"R15-2-20210130","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djg050","article-title":"Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer","volume":"95","author":"Foulkes","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R16-2-20210130","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals","volume":"20","author":"Frank","year":"2002","journal-title":"J Clin Oncol"},{"key":"R17-2-20210130","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","article-title":"Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk","volume":"16","author":"Frank","year":"1998","journal-title":"J Clin Oncol"},{"key":"R18-2-20210130","first-page":"1481","article-title":"Molecular-cytogenetic analysis of Her-2\/neu gene in BRCA1-associated breast cancers","volume":"62","author":"Grushko","year":"2002","journal-title":"Cancer Res"},{"key":"R19-2-20210130","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(05)64441-8","article-title":"Intraductal component of BRCA1 associated breast cancer","volume":"348","author":"Jacquemier","year":"1996","journal-title":"Lancet"},{"key":"R20-2-20210130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y","article-title":"Influence of BRCA1 mutations in nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women","volume":"80","author":"Karp","year":"1997","journal-title":"Cancer"},{"key":"R21-2-20210130","first-page":"782","article-title":"The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2","volume":"6","author":"Lakhani","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R22-2-20210130","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","article-title":"Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations","volume":"90","author":"Lakhani","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R23-2-20210130","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1158\/1078-0432.CCR-04-2424","article-title":"Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype","volume":"11","author":"Lakhani","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R24-2-20210130","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","article-title":"The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2","volume":"20","author":"Lakhani","year":"2002","journal-title":"J Clin Oncol"},{"key":"R25-2-20210130","first-page":"1206","article-title":"Major improvement in the efficacy of BRCA1 mutation screening using morphological features of breast cancer","volume":"60","author":"Lindereau","year":"2000","journal-title":"Cancer Res"},{"key":"R27-2-20210130","first-page":"23","article-title":"Pathology and heredity of breast cancer in younger women","volume":"16","author":"Marcus","year":"1994","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R29-2-20210130","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0140-6736(98)24020-7","article-title":"Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers","volume":"351","author":"Osin","year":"1998","journal-title":"Lancet"},{"key":"R30-2-20210130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"R31-2-20210130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/cncr.10223","article-title":"Model-based predictions of BRCA1\/2 mutation status in breast carcinoma patients treated at an academic medical center","volume":"94","author":"Shannon","year":"2002","journal-title":"Cancer"},{"key":"R32-2-20210130","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.1997.03550150046034","article-title":"BRCA1 sequence analysis in women at high risk for susceptibility mutations","volume":"278","author":"Shattuck-Eidens","year":"1997","journal-title":"JAMA"},{"key":"R33-2-20210130","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.2002.20.4.994","article-title":"BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic","volume":"20","author":"Shih","year":"2002","journal-title":"J Clin Oncol"},{"key":"R34-2-20210130","article-title":"Medical Decision Making","author":"Sox","year":"1988"},{"key":"R35-2-20210130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1023\/A:1008396129543","article-title":"A comparison of methods currently used in clinical practice to estimate familial breast cancer risks [In Process Citation]","volume":"11","author":"Tischkowitz","year":"2000","journal-title":"Ann Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000478-200611000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:40:06Z","timestamp":1785948006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000478-200611000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pas.0000213273.22844.1a","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}